Found 4363 articles for: ""
Blood Monocyte Count Can Predict Early Response to Secukinumab Therapy in Patients With Psoriasis
February 2024 | Volume 23 | Issue 2 | Original Article | 74 | Copyright © February 2024
Early response to treatment with biologics, defined as Psoriasis Area and Severity Index (PASI) of 2 or less six months after initiation of therapy, seems to be associated with more stable psoria...
Read MoreAtypical Dyschromia in Skin of Color
February 2024 | Volume 23 | Issue 2 | Case Reports | 100 | Copyright © February 2024
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with ...
Read MoreTargeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis
February 2024 | Volume 23 | Issue 2 | Original Article | 23 | Copyright © February 2024
Atopic dermatitis (AD) is a chronic relapsing–remitting disease with a multifactorial etiology involving epidermal barrier and immunologic dysfunction. Topical therapies form the mainstay o...
Read MoreAtopic Dermatitis as a Paradoxical Reaction to Secukinumab in a Patient With Plaque Psoriasis
February 2024 | Volume 23 | Issue 2 | Case Reports | 97 | Copyright © February 2024
Paradoxical reactions to biologic agents used in the treatment of psoriasis are rare but have been reported with tumor necrosis factor (TNF) blockers and, more recently, with interleukin (IL)-17A...
Read MoreSarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Neoadjuvant PD-1 Inhibitors: A Tale of Two Cases
February 2024 | Volume 23 | Issue 2 | Case Reports | e57 | Copyright © February 2024
Treatment responses for locally advanced cutaneous squamous cell carcinoma (cSCC) and Merkel cell carcinoma (MCC) are often short lived and are marred with recurrences. The introduction of adjuva...
Read MoreApplications of Bioactive Peptides in Dermatology
January 2024 | Volume 23 | Issue 1 | Features | 1369 | Copyright © January 2024
Comparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness
January 2024 | Volume 23 | Issue 1 | Original Article | 1260 | Copyright © January 2024
Dyschromia is the result of irregular facial pigmentation. These cutaneous manifestations can have a significant impact on the quality of life of those affected, especially among females and skin...
Read MoreObjective Facial Assessment With Artificial Intelligence: Introducing the Facial Aesthetic Index and Facial Youthfulness Index
January 2024 | Volume 23 | Issue 1 | Editorials | e52 | Copyright © January 2024
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreRevolutionizing Neck Rejuvenation: ABO Botulinum Toxin A Solution in Multipoint Technique and NASHA Gel Skinbooster
January 2024 | Volume 23 | Issue 1 | Original Article | 1344 | Copyright © January 2024
Background: Neck rejuvenation is an increasingly sought-after cosmetic procedure that offers a versatile solution to address various aging-related concerns in the neck area. Beca...
Read MoreValidation of a Midfacial Scale and Its Use in a Randomized, Evaluator-Blinded Study of CPM-HA-V
January 2024 | Volume 23 | Issue 1 | Original Article | 1284 | Copyright © January 2024
Background: Age-related loss of midfacial contour is frequently corrected using dermal fillers. A validated photonumeric scale is beneficial when evaluating post-treatment aesthe...
Read MoreCurrent Landscape of Hyaluronic Acid Filler Use in the United States
January 2024 | Volume 23 | Issue 1 | Original Article | 1247 | Copyright © January 2024
Background: Hyaluronic acid (HA) fillers are among the most used fillers for soft-tissue augmentation. There are now many FDA-approved HA products, and the successful use of inje...
Read MoreEvaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris
January 2024 | Volume 23 | Issue 1 | Original Article | 1274 | Copyright © January 2024
Background: Keratosis pilaris (KP) is a benign dermatosis consisting of folliculocentric keratotic papules or pustules with surrounding erythema, often on proximal extensor surfaces of extremitie...
Read MoreInternational Consensus on Anti-Aging Dermocosmetics and Skin Care for Clinical Practice Using the RAND/UCLA Appropriateness Method
January 2024 | Volume 23 | Issue 1 | Original Article | 1337 | Copyright © January 2024
Background: The objective was to provide international recommendations on anti-aging dermocosmetics for clinical practice starting with essential ingredients for protection and r...
Read MoreEffectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles
January 2024 | Volume 23 | Issue 1 | Original Article | 1297 | Copyright © January 2024
Background: The current study evaluated the effectiveness and safety of Sculptra injectable poly-L-lactic acid (PLLA-SCA) treatment in correcting cheek wrinkles compared wit...
Read MoreA Two-Stage Injection Technique and Dose-Ranging Study Using High-Dose AbobotulinumtoxinA for Treating Platysmal Bands
January 2024 | Volume 23 | Issue 1 | Original Article | 1311 | Copyright © January 2024
Background: AbobotulinumtoxinA (aboBoNT-A) is useful for the treatment of platysmal banding. This study evaluated the efficacy and safety of a standardized 2-staged injection tec...
Read MoreQuantifiable Changes in the Submental Area and Mandible Border After Dual-Modality Treatment With ATX-101 and VYC-20L for Overall Improvement in Jawline Contour
January 2024 | Volume 23 | Issue 1 | Original Article | 1325 | Copyright © January 2024
Background: A phase 4, prospective, open-label, multicenter study showed that treatment with deoxycholic acid injections (ATX-10) followed by a hyaluronic acid filler (VYC-20L) i...
Read MoreOptimized Patient Outcomes With the Novel Modality of Corrective Chemical Peel and Neurotoxin on Same-Day Treatment
January 2024 | Volume 23 | Issue 1 | Original Article | 1349 | Copyright © January 2024
Background: This study was conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. Chemical Peels and Neurotoxins have been trad...
Read MoreA Retrospective Analysis of Patient Satisfaction With a Graft-Based Non-Surgical Rhinoplasty Procedure Using a Modified Surgical Rhinoplasty Module
January 2024 | Volume 23 | Issue 1 | Original Article | 1292 | Copyright © January 2024
Media and other results for: ""